Opinion

Video

Second-line Treatment Landscape in Relapsed/Refractory DLBCL

A concise discussion of second-line treatment options for DLBCL, focusing on preferred regimens for transplant-eligible and ineligible patients, and tailored approaches based on relapse timing.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Video content above is prompted by the following:

    Briefly discuss second-line (2L) treatment of DLBCL.

    • What are preferred regimens for transplant ineligible versus transplant eligible?
    • What are preferred regimens for patients that relapse within 12 months versus those that do not progress within 12 months?